LB Pharmaceuticals Inc
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About LB Pharmaceuticals Inc
LB Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing novel therapies for the treatment of schizophrenia, bipolar depression, and other neuropsychiatric diseases. It is building a pipeline that leverages the broad therapeutic potential of its lead product candidate, LB-102, which the company believes has the potential to be the first benzamide antipsychotic drug approved for neuropsychiatric disorders in the United States. LB-102 is a new chemical entity and a methylated derivative of amisulpride, a second-generation antipsychotic drug approved in over 50 countries.
/ 
Frequently asked questions
To buy LB Pharmaceuticals Inc stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for LB Pharmaceuticals Inc by name or ticker, choose the number of shares, and place your order.
The ticker symbol for LB Pharmaceuticals Inc is LBRX:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
LB Pharmaceuticals Inc has its primary listing on NASDAQ. You can trade LB Pharmaceuticals Inc with a Saxo account, alongside thousands of other stocks worldwide.
Yes, LB Pharmaceuticals Inc is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include LB Pharmaceuticals Inc as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like LB Pharmaceuticals Inc.